New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - quinapril hydrochloride 21.7mg equivalent to 20 mg quinapril;  ; quinapril hydrochloride 21.7mg equivalent to 20 mg quinapril - film coated tablet - 20 mg - active: quinapril hydrochloride 21.7mg equivalent to 20 mg quinapril   excipient: crospovidone heavy magnesium carbonate hyprolose iron oxide yellow isopropyl alcohol macrogol 6000 magnesium stearate methacrylic acid copolymer purified talc titanium dioxide active: quinapril hydrochloride 21.7mg equivalent to 20 mg quinapril excipient: crospovidone heavy magnesium carbonate hyprolose iron oxide yellow isopropyl alcohol macrogol 6000 magnesium stearate methacrylic acid copolymer purified talc titanium dioxide - quinapril is indicated for the treatment of essential hypertension. quinapril is effective as monotherapy or concomitantly with diuretics and beta-blockers in patients with hypertension. quinapril is effective in the treatment of congestive heart failure when given concomitantly with a diuretic and/or digoxin.

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - quinapril hydrochloride 5.425mg equivalent to 5 mg quinapril;  ; quinapril hydrochloride 5.425mg equivalent to 5 mg quinapril - film coated tablet - 5 mg - active: quinapril hydrochloride 5.425mg equivalent to 5 mg quinapril   excipient: crospovidone heavy magnesium carbonate hyprolose iron oxide yellow isopropyl alcohol macrogol 6000 magnesium stearate methacrylic acid copolymer purified talc titanium dioxide active: quinapril hydrochloride 5.425mg equivalent to 5 mg quinapril excipient: crospovidone heavy magnesium carbonate hyprolose iron oxide yellow isopropyl alcohol macrogol 6000 magnesium stearate methacrylic acid copolymer purified talc titanium dioxide - quinapril is indicated for the treatment of essential hypertension. quinapril is effective as monotherapy or concomitantly with diuretics and beta-blockers in patients with hypertension. quinapril is effective in the treatment of congestive heart failure when given concomitantly with a diuretic and/or digoxin.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - cilazapril monohydrate 2.61mg equivalent to cilazapril 2.5 mg - film coated tablet - 2.5 mg - active: cilazapril monohydrate 2.61mg equivalent to cilazapril 2.5 mg excipient: colloidal silicon dioxide lactose opadry pink 40l14839 pregelatinised maize starch sodium bicarbonate sodium stearyl fumarate - zapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. zapril is also indicated in the treatment of congestive heart failure as an adjunctive therapy with digitalis and/or diuretics.

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - cilazapril monohydrate 5.22mg equivalent to cilazapril 5 mg - film coated tablet - 5 mg - active: cilazapril monohydrate 5.22mg equivalent to cilazapril 5 mg excipient: colloidal silicon dioxide lactose opadry brown 40l16820 pregelatinised maize starch sodium bicarbonate sodium stearyl fumarate - zapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. zapril is also indicated in the treatment of congestive heart failure as an adjunctive therapy with digitalis and/or diuretics.

Israel - English - Ministry of Health

dexcel ltd, israel - enalapril maleate; lercanidipine hydrochloride - tablets - lercanidipine hydrochloride 10 mg; enalapril maleate 20 mg - enalapril - enalapril - treatment of essential hypertension in patients whose blood pressure cannot be adequately controlled under enalapril monotherapy.

Israel - English - Ministry of Health

dexcel ltd, israel - enalapril maleate; lercanidipine hydrochloride - tablets - lercanidipine hydrochloride 10 mg; enalapril maleate 10 mg - enalapril - enalapril - treatment of essential hypertension in patients whose blood pressure cannot be adequately controlled under lercanidipine monotherapy.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - sildenafil as citrate - film coated tablets - sildenafil as citrate 25 mg - sildenafil - sildenafil - treatment of erectile dysfunction.

Israel - English - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - sildenafil as citrate - film coated tablets - sildenafil as citrate 100 mg - sildenafil - sildenafil - treatment of erectile dysfunction.

European Union - English - EMA (European Medicines Agency)

upjohn eesv - sildenafil - erectile dysfunction - urologicals - treatment of men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.in order for viagra to be effective, sexual stimulation is required.

European Union - English - EMA (European Medicines Agency)

upjohn eesv - sildenafil - hypertension, pulmonary - urologicals - treatment of adult patients with pulmonary arterial hypertension classified as world health organization (who) functional class ii and iii, to improve exercise capacity. efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease.paediatric populationtreatment of paediatric patients aged one year to 17 years old with pulmonary arterial hypertension. efficacy in terms of improvement of exercise capacity or pulmonary haemodynamics has been shown in primary pulmonary hypertension and pulmonary hypertension associated with congenital heart disease.revatio solution for injection is for the treatment of adult patients with pulmonary arterial hypertension who are currently prescribed oral revatio and who are temporarily unable to take oral therapy, but are otherwise clinically and haemodynamically stable.revatio (oral) is indicated for treatment of adult patients with pulmonary arterial hypertension classified as who functional class ii and iii, to improve exercise capacity. efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease.